Annual Debt To Equity
-0.78
-2.20-154.93%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual debt to equity ratio is -0.78, with the most recent change of -2.20 (-154.93%) on December 31, 2023.
- During the last 3 years, NRXP annual debt to equity has fallen by -0.76 (-3800.00%).
- NRXP annual debt to equity is now -154.93% below its all-time high of 1.42, reached on December 31, 2022.
Performance
NRXP Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-0.35
+0.07+16.67%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly debt to equity ratio is -0.35, with the most recent change of +0.07 (+16.67%) on September 30, 2024.
- Over the past year, NRXP quarterly debt to equity has increased by +0.10 (+22.22%).
- NRXP quarterly debt to equity is now -124.65% below its all-time high of 1.42, reached on December 31, 2022.
Performance
NRXP Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
NRXP Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -154.9% | +22.2% |
| 3 y3 years | -3800.0% | -100.0% |
| 5 y5 years | -3800.0% | - |
NRXP Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -154.9% | at low | -124.7% | +99.2% |
| 5 y | 5-year | -154.9% | at low | -124.7% | +99.2% |
| alltime | all time | -154.9% | at low | -124.7% | +99.2% |
NRx Pharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -0.35(-16.7%) |
| Jun 2024 | - | -0.42(-6.7%) |
| Mar 2024 | - | -0.45(-42.3%) |
| Dec 2023 | -0.78(-154.9%) | -0.78(-51.9%) |
| Sep 2023 | - | -1.62(-64.2%) |
| Jun 2023 | - | -4.52(-89.5%) |
| Mar 2023 | - | -42.92(-3122.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | 1.42(+7000.0%) | 1.42(>+9900.0%) |
| Sep 2022 | - | 0.00(0.0%) |
| Jun 2022 | - | 0.00(-100.0%) |
| Mar 2022 | - | 0.02(0.0%) |
| Dec 2021 | 0.02(-200.0%) | 0.02(-66.7%) |
| Sep 2021 | - | 0.06(-250.0%) |
| Jun 2021 | - | -0.04(+100.0%) |
| Dec 2020 | -0.02 | -0.02 |
FAQ
- What is NRx Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual debt to equity year-on-year change?
- What is NRx Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly debt to equity year-on-year change?
What is NRx Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of NRXP is -0.78
What is the all time high annual debt to equity for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual debt to equity ratio is 1.42
What is NRx Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, NRXP annual debt to equity ratio has changed by -2.20 (-154.93%)
What is NRx Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of NRXP is -0.35
What is the all time high quarterly debt to equity for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly debt to equity ratio is 1.42
What is NRx Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, NRXP quarterly debt to equity ratio has changed by +0.10 (+22.22%)